Why You Should File a Product Liability Actonel Lawsuit

If you are currently on Actonel, you may be entitled to compensation due to the side effects it causes. These side effects can significantly limit your quality of life, require expensive medical treatments, and even result in death. If you have suffered from an unforeseen side effect of Actonel, the manufacturer of the drug may be legally responsible. It may be that the drug was defective, or that the manufacturer failed to adequately warn about the potential side effects. If this was the case, the drug manufacturer may be held strictly liable for your injuries. A product liability lawsuit against the drugmaker is a good option for anyone suffering from side effects from Actonel. In most cases, patients need not have been negligent in purchasing the drug. However, they must link the side effects to the complications they experience.

Actonel causes femur fractures

Actonel is a bisphosphonate drug that slows the bone remodeling process. Bone remodeling is necessary for repairing small breaks in bones, but when you take Actonel, your body stops doing it properly. As a result, you may experience repeated low-energy fractures in your femur. The U.S. Food and Drug Administration began an investigation into bisphosphonate drugs in 2010 and found an association between the drugs and serious femur fractures.

Bisphosphonates increase the risk of femur fractures

Women who take bisphosphonates have an increased risk of atypical femur fractures, but the study also found a significant reduction in risk after discontinuation. Specifically, discontinuation of bisphosphonates reduced the risk of atypical femur fractures by 48% over the first three to 15 months, and by 74-79% over the next two years. This study emphasized the need to tailor treatment to each patient’s unique risk factors.

Bisphosphonates increase the risk of Stevens-Johnson syndrome

Long-term use of bisphosphonates has been linked to osteonecrosis of the external auditory canal (OAEC). Patients receiving these medications must also be monitored for chronic ear infections and steroid use to reduce the risk. These medications are also associated with esophagitis. The symptoms of OAEC are often mild and can be difficult to detect, but if they develop, a physician can treat the condition.

Fosamax increases the risk of atrial fibrillation

A recent study found that women who took Fosamax increased their risk of atrial fibrillation by double. The drug is one of the most popular treatments for osteoporosis. The FDA approved the first generic Fosamax in February. Despite these findings, it is still possible that bisphosphonates can cause atrial fibrillation. The researchers say that the new study should be conducted with caution and with an open mind.

Fosamax increases the risk of esophageal irritation

An FDA official has said that there is a link between the bisphosphonate drug Fosamax and an increased risk of esophageal irritation, or esophagitis. In a letter to the New England Journal of Medicine, the agency noted that it has received 23 reports of esophageal tumors linked to Fosamax. The FDA stated that the reports were rare, but that it is still worth investigating. The company is currently approved to sell the drug in the United States.

Aredia increases the risk of esophageal irritation

A new drug marketed by Novartis, Aredia, has been linked to serious bone disease. Osteomyelitis and a dead jaw are two of the possible side effects of Aredia. Additionally, femur and hip fractures have been reported in patients taking Aredia. Although the FDA has not yet ruled on whether the drug is the cause of these side effects, Novartis has informed doctors and dentists of the risk of esophageal irritation with this medication.

Boniva increases the risk of atrial fibrillation

According to the lawsuit, this drug has increased the risk of bone fractures in patients who already have atrial fibrillation. The drug is bisphosphonate, a type of drug that is used for bone-building purposes. Despite its many names, it is most commonly used for osteoporosis. But it is also approved for the treatment of Paget’s disease and is given to cancer patients to prevent bone metastases.

Leave a Reply

Your email address will not be published. Required fields are marked *